Centessa Pharmaceuticals PLC banner

Centessa Pharmaceuticals PLC
F:260

Watchlist Manager
Centessa Pharmaceuticals PLC Logo
Centessa Pharmaceuticals PLC
F:260
Watchlist
Price: 33.4 EUR 1.83%
Market Cap: €3.8B

Wall St Price Targets

Price Targets Summary
Centessa Pharmaceuticals PLC

Wall Street analysts forecast Centessa Pharmaceuticals PLC stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Centessa Pharmaceuticals PLC is 37.06 EUR with a low forecast of 29.48 EUR and a high forecast of 54.29 EUR.

Lowest Forecast
Price Target
29.48 EUR
12% Downside
Average Forecast
Price Target
37.06 EUR
11% Upside
Highest Forecast
Price Target
54.29 EUR
63% Upside
Centessa Pharmaceuticals PLC Competitors:
Price Targets
PTCT
PTC Therapeutics Inc
28% Upside
VYNE
Vyne Therapeutics Inc
204% Upside
ISSC
Innovative Solutions and Support Inc
73% Upside

Revenue
Forecast

N/A
Past Growth
87% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
87% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

The compound annual growth rate for Revenue over the next 8 years is 87%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-9%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-9%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is Centessa Pharmaceuticals PLC's stock price target?
Price Target
37.06 EUR

According to Wall Street analysts, the average 1-year price target for Centessa Pharmaceuticals PLC is 37.06 EUR with a low forecast of 29.48 EUR and a high forecast of 54.29 EUR.

What is the Revenue forecast for Centessa Pharmaceuticals PLC?
Projected CAGR
87%

The compound annual growth rate for Revenue over the next 8 years is 87%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett